TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 150 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2016. The put-call ratio across all filers is 2.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $263,000 | +29.6% | 3,475 | +46.3% | 0.00% | +50.0% |
| Q2 2019 | $203,000 | -5.1% | 2,375 | +20.3% | 0.00% | 0.0% |
| Q1 2019 | $214,000 | +151.8% | 1,975 | +97.5% | 0.00% | +100.0% |
| Q4 2018 | $85,000 | -13.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $98,000 | -15.5% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $116,000 | -55.2% | 1,000 | -56.5% | 0.00% | -50.0% |
| Q3 2017 | $259,000 | +44.7% | 2,300 | +43.8% | 0.00% | 0.0% |
| Q2 2017 | $179,000 | -4.3% | 1,600 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $187,000 | +11.3% | 1,600 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $168,000 | +281.8% | 1,600 | +300.0% | 0.00% | – |
| Q3 2016 | $44,000 | -81.1% | 400 | -75.0% | 0.00% | -100.0% |
| Q2 2016 | $233,000 | +28.0% | 1,600 | +35.9% | 0.00% | 0.0% |
| Q4 2015 | $182,000 | – | 1,177 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 94,031 | $10,164,000 | 2.02% |
| ALTERNA WEALTH MANAGEMENT, INC | 20,530 | $2,219,000 | 1.88% |
| Strategic Global Advisors, LLC | 72,308 | $7,816,000 | 1.64% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $3,074,000 | 0.95% |
| Freestone Capital Holdings, LLC | 129,757 | $14,025,000 | 0.83% |
| Hudson Capital Management LLC | 12,394 | $1,339,667,000 | 0.82% |
| FORT, L.P. | 19,158 | $2,071,000 | 0.42% |
| MENTA CAPITAL LLC | 6,880 | $744,000 | 0.32% |
| Empirical Finance, LLC | 9,511 | $1,028,000 | 0.26% |
| ALGERT GLOBAL LLC | 4,071 | $440,000 | 0.25% |